Outcomes of SGLT2 Inhibitors Use in Diabetic Renal Transplant Patients

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are newly introduced hypoglycemic drugs that work by inhibiting glucose reabsorption at proximal renal tubules. The use of SGLT2 inhibitors in nontransplant diabetic patients with or without cardiovascular disease has well-established efficacy and sa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation proceedings 2020-01, Vol.52 (1), p.175-178
Hauptverfasser:	AlKindi, Fatima, Al-Omary, Hanan L., Hussain, Qutaiba, Al Hakim, Mohamed, Chaaban, Ahmed, Boobes, Yousef
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!